Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding

Background: Patients with liver cirrhosis and gastrointestinal bleeding (GIB) often develop anemia. Ferric carboxymaltose (FCM) is an intravenous (i.v.) iron formulation approved for use in patients with iron deficiency with inadequate response to oral iron therapy or when oral iron cannot be used....

Full description

Saved in:
Bibliographic Details
Published in:Front Med (Lausanne)
Main Authors: Ballester-Clau, Raquel, Torres Vicente, Gisela, Cucala Ramos, Mercedes, Aracil Blanch, Carles, Miñana Calafat, Josep Maria, Pijoan Comas, Eva, Reñé Espinet, Josep Maria, Planella de Rubinat, Montse
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Medicine
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7181670/
https://ncbi.nlm.nih.gov/pubmed/32363194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.00128
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items